Provided by Tiger Trade Technology Pte. Ltd.

CSPC PHARMA

9.525
+0.1151.22%
Volume:190.28M
Turnover:1.84B
Market Cap:109.75B
PE:24.03
High:9.980
Open:9.505
Low:9.430
Close:9.410
52wk High:11.203
52wk Low:6.387
Shares:11.52B
HK Float Shares:11.52B
Volume Ratio:1.04
T/O Rate:1.65%
Dividend:0.29
Dividend Rate:3.04%
EPS(LYR):0.396
ROE:20.90%
ROA:10.70%
PB:2.50
PE(LYR):24.03
PS:3.00

Loading ...

CSPC Says FDA Clears US Clinical Trial for SYS 6037 Mpox mRNA Vaccine

Reuters
·
Aug 10

CSPC Pharmaceutical - Sys6037 Mpox Mrna Vaccine Obtains FDA Clinical Trial Approval in U.S.

THOMSON REUTERS
·
Aug 10

Movement Alert|CSPC PHARMA Rises 4.43% in Regular Trading, AstraZeneca Collaboration Deepens with Milestone Payment and Joint Venture

Market Focus
·
Aug 10

CSPC Pharmaceutical Group Stock Advances 1.5% in Hong Kong, Outperforms Competitors

Dow Jones
·
Aug 06

Hong Kong Stock Exchange News Highlights: Beone Medicines Sees 111% Surge in Adjusted Net Profit for First Half of the Year

Stock News
·
Aug 06

CSPC Pharma Secures US$10.00 million Milestone Payment from AstraZeneca under Small-Molecule R&D Pact

Bulletin Express
·
Aug 05

CSPC Pharmaceutical Receives USD 10 Million AstraZeneca Milestone Payment Under Research Pact

Reuters
·
Aug 05

CSPC Pharma and AstraZeneca to Establish 51/49 Joint Venture for Next-Generation Biologics Facility in Shijiazhuang

Bulletin Express
·
Aug 05

CSPC Pharmaceutical and AstraZeneca Enter JV for Biologics Facility in China

Reuters
·
Aug 05

CSPC Pharmaceutical Group Stock Falls 1.3% in Hong Kong, Underperforms Competitors

Dow Jones
·
Aug 05

CSPC Pharma, AstraZeneca Form Biologics Manufacturing JV in China with 51%-49% Split

Reuters
·
Aug 05

CSPC Pharmaceutical - Co to Hold 51% and AstraZeneca 49% in Joint Venture

THOMSON REUTERS
·
Aug 05

CSPC Pharmaceutical - Joint Venture to Manufacture Biologics Drug Substances for Global Markets

THOMSON REUTERS
·
Aug 05

CSPC Pharma Unit, Alphamab Oncology's Breast Cancer Drug Application Granted Priority Review in China

MT Newswires Live
·
Aug 04

CSPC Says NMPA Accepts NDA for Anbenitamab, Albumin-Bound Docetaxel Neoadjuvant Breast Cancer Combo Under Priority Review

Reuters
·
Aug 04

Alphamab Oncology Says NMPA Accepts NDA for Anbenitamab (kn026)

Reuters
·
Aug 04

CSPC Pharma Begins Phase Ib/II Trial of Colorectal Cancer Drug Candidate

MT Newswires Live
·
Aug 03

CSPC Pharmaceutical - Initiates Phase Ib/Ii Trial of Sys 6090 Injection for Colorectal Cancer in China

THOMSON REUTERS
·
Aug 03

CSPC Pharmaceutical Group Stock Falls 1.3% in Hong Kong

Dow Jones
·
Aug 03

Movement Alert|CSPC PHARMA Falls 3.03% in Regular Trading, Trading at HK$8.31

Market Focus
·
Aug 03